Evidence
Nitric Oxide. 2024 Feb 19:S1089-8603(24)00018-1. doi: 10.1016/j.niox.2024.02.001. Online ahead of print.
ABSTRACT
OBJECTIVE: Hydrogen sulfide (H2S) is associated with depressive-like behavior in rodents. We undertook cross-sectional and longitudinal analyses of plasma levels of H2S and its substrate homocysteine (Hcy) in depression and assessed the association of both parameters with psychopathology and cognitive function.
METHODS: Forty-one patients suffering from depression (PSDs) and 48 healthy volunteers were recruited. PSDs were treated for 8 weeks. Analyzable data were collected from all participants for assessment of their psychopathology and cognitive function. Plasma was collected for determination of levels of H2S and Hcy, and data were correlated to determine their potential as plasma biomarkers.
RESULTS: Cross-sectional analyses revealed PSDs to have a low plasma H2S level and high Hcy level. Longitudinal analyses revealed that 8 weeks of treatment reversed the changes in plasma levels of H2S and Hcy in PSDs. Plasma levels of H2S and Hcy were associated with psychopathology and cognitive function in depression. The area under the receiver operating characteristic curve (AUC) for a combination of plasma levels of H2S and Hcy and expression of the TNF gene (i.e., H2S-Hcy-TNF) was 0.848 for diagnosing depression and 0.977 for predicting the efficacy of antidepressant agents.
CONCLUSION: Plasma levels of H2S and Hcy reflect changes in psychopathology and cognitive function in depression and H2S-Hcy-TNF has the potential to diagnose depression and predict the efficacy of antidepressant medications.
PMID:38382866 | DOI:10.1016/j.niox.2024.02.001
Add to Google Keep
Estimated reading time: 5 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
Plasma levels of hydrogen sulfide and homocysteine correlate with the efficacy of antidepressant agents and serve as potential diagnostic and therapeutic markers
🌐 90 Days
VR Related Evidence Matrix
- Serum interleukin-17 A and homocysteine levels in children with autism
- Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin
- Simultaneous SERS Sensing of Cysteine and Homocysteine in Blood Based on the CBT-Cys Click Reaction: Toward Precisive Diagnosis of Schizophrenia
- The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study
- Quantification of Plasma Dopamine in Depressed Patients Using Silver-Enriched Silicon Nanowires as SERS-Active Substrates
- Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease
- Sleep and APOE-ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Correlation analysis between cerebral microangiopathy and autonomic nervous dysfunction
- Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals
- The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study
- Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia
- Exogenous hydrogen sulfide ameliorates diabetes-associated cognitive dysfunction by regulating the nrf-2/HO-1 axis and the NLRP3 inflammasome pathway in diabetic rats
- Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
- Cognitive protection and brain entropy changes from omega-3 polyunsaturated fatty acids supplement in late-life depression: A 52-week randomized controlled trial
- Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis
- Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects
- Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis
- Hydrogen sulfide mitigates memory impairments via the restoration of glutamatergic neurons in a mouse model of hemorrhage shock and resuscitation
- Autoantibodies against acetylcholine receptors are increased in archived serum samples from patients with schizophrenia
- Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder
- Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV
- Changes in pain during a depressive episode and relationship to cytokine levels in major depressive disorder
- Higher orexin-A levels are associated with treatment response to clozapine in patients with schizophrenia: A cross-sectional study
- The effectiveness of vortioxetine on neurobiochemical metabolites and cognitive of major depressive disorders patients: A 8-week follow-up study
- Silent Infections are not So Silent: The Emerging Role of Combined Infections, Inflammation, and Vitamin Levels in OCD
- Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization
- Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization
- Prevalence of Eating Disorders and Comorbidity With Depression Among Adolescents in Saudi Arabia: A Cross-Sectional Study
- Serial multiple mediating roles of anxiety and thyroid-stimulating hormone in the relationship between depression and psychotic symptoms in young adults with anxious depression
- Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia
- Relation of Sleep Quality to a Panel of Plasma Cardiometabolic Markers in Airline Pilots: A Cross-Sectional Study
- Plasma biomarkers of Alzheimer's disease and related dementias in American Indians: The Strong Heart Study
- Circulating extracellular vesicles as biomarker for diagnosis, prognosis and monitoring in glioblastoma patients
- Peripheral amyloid-beta clearance mediates cognitive impairment in non-alcoholic fatty liver disease
- The magnitude of the plasma hepcidin response to oral iron supplements depends on the iron dosage
- Sleep problems as predictors of cognitive decline in essential tremor: A prospective longitudinal cohort study
- The atorvastatin metabolite pattern in muscle tissue and blood plasma is associated with statin muscle side effects in patients with coronary heart disease; An exploratory case-control study
- Association of healthy eating index (2015) with depression and anxiety symptoms among Iranian adolescent girls
- Association between serum trace element, mineral, and amino acid levels with non-alcoholic fatty liver disease (NAFLD) in adult women
- Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia
- Effectiveness of Peer-Based and Conventional Video Education in Reducing Perioperative Depression and Anxiety Among Coronary Artery Bypass Grafting Patients: A Randomized Controlled Trial
- Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick. An expert consensus paper
- Plasma of COVID-19 Patients Does Not Alter Electrical Resistance of Human Endothelial Blood-Brain Barrier In Vitro
- Sex differences in the effects of repeated ketamine infusions on bone markers in patients with unipolar and bipolar depression
- Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies
- Relationships between cortisol levels across early childhood and processing speed at age 4.5 years in children born very preterm
- Gender difference on the mediation effects of filial piety on the association between chronic obstructive pulmonary disease and depressive symptoms in older adults: A community-based study
- Can Muscular Parameters Predict Symptoms of Anxiety and Depression?
- Genetically Determined Plasma Hepatocyte Growth Factor Levels Are Associated With the Risk and Prognosis of Ischemic Stroke
- Genetically Determined Plasma Hepatocyte Growth Factor Levels Are Associated With the Risk and Prognosis of Ischemic Stroke
- Ghrelin and depressive symptoms in patients with first-episode drug-naïve major depressive disorder: The mediating role of hypothalamic-pituitary-adrenal axis
- A UPLC-MS/MS method for simultaneous determination of arachidonic acid, stearic acid, and related endocannabinoids in human plasma
- Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort
- Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohorts
- Association of Plasma Markers of Alzheimer's Disease, Neurodegeneration, and Neuroinflammation with the Choroid Plexus Integrity in Aging
- Association between type 2 diabetes and depressive symptoms after a 1-year follow-up in an older adult Mediterranean population
- Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers
- Salivary Galectin 3 Levels in Schizophrenia Patients
- Vascular dysfunction in sporadic bvFTD: white matter hyperintensity and peripheral vascular biomarkers
- Proteomic insights into mental health status: plasma markers in young adults
- Investigating amplitude of low-frequency fluctuation and possible links with cognitive impairment in childhood and adolescence onset schizophrenia: a correlation study
Evidence Blueprint
Plasma levels of hydrogen sulfide and homocysteine correlate with the efficacy of antidepressant agents and serve as potential diagnostic and therapeutic markers
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Plasma levels of hydrogen sulfide and homocysteine correlate with the efficacy of antidepressant agents and serve as potential diagnostic and therapeutic markers
🌐 365 Days
VR Related Evidence Matrix
- Hydrogen sulfide and liver health: Insights into liver diseases
- Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine diet
- Association of Prolactin, Oxytocin and Homocysteine with the clinical and cognitive features of a First Episode of Psychosis over a 1-year follow-up
- QTL mapping reveals novel genes and mechanisms underlying variations in H2S production during alcoholic fermentation in Saccharomyces cerevisiae
- Effects of extended-release 7-nitroindazole gel formulation treatment on the behavior of Shank3 mouse model of autism
- Serum interleukin-17 A and homocysteine levels in children with autism
- Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin
- Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment
- Susceptibility to preoperative seizures in glioma patients with elevated homocysteine levels
- Simultaneous SERS Sensing of Cysteine and Homocysteine in Blood Based on the CBT-Cys Click Reaction: Toward Precisive Diagnosis of Schizophrenia
- The relationship between serum prolactin levels and cognitive function in drug-naïve schizophrenia patients: a cross-sectional study
- Quantification of Plasma Dopamine in Depressed Patients Using Silver-Enriched Silicon Nanowires as SERS-Active Substrates
- The relationship between inflammatory markers, clinical characteristics, and cognitive performance in drug-naïve patients with schizophrenia
- Association between plasma CTRPs with cognitive impairment and neurodegeneration of Alzheimer's disease
- Sleep and APOE-ε4 have a synergistic effect on plasma biomarkers and longitudinal cognitive decline in older adults
- High plasma nesfatin-1 level in Chinese adolescents with depression
- Association between suicidal behavior and impaired glucose metabolism in first-episode drug-naïve patients with schizophrenia
- Characteristics of discordance between amyloid positron emission tomography and plasma amyloid-β 42/40 positivity
- Levels of neuronal pentraxin 2 in plasma is associated with cognitive function in patients with schizophrenia
- Correlation analysis between cerebral microangiopathy and autonomic nervous dysfunction
- Associatons Between Ageing And Vitamin D Status With Whole-Body Nitric Oxide Production And Markers Of Endothelial Function
- Polygenic risk for Alzheimer's disease is associated with neuroaxonal damage before onset of clinical symptoms
- Altered In vivo early neurogenesis traits in patients with depression: Evidence from neuron-derived extracellular vesicles and electroconvulsive therapy
- Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals
- The Relationship between Alterations in Plasma Metabolites and Treatment Responses in Antipsychotic-Naïve Female Patients with Schizophrenia
- The impact of kidney function on plasma neurofilament light and phospho-tau 181 in a community-based cohort: the Shanghai Aging Study
- Association of Plasma YKL-40 With MRI, CSF, and Cognitive Markers of Brain Health and Dementia
- Exogenous hydrogen sulfide ameliorates diabetes-associated cognitive dysfunction by regulating the nrf-2/HO-1 axis and the NLRP3 inflammasome pathway in diabetic rats
- Plasma NT1-tau and Aβ42 correlate with age and cognitive function in two large Down syndrome cohorts
- Plasma Amino Acids in NAFLD Patients with Obesity Are Associated with Steatosis and Fibrosis: Results from the MAST4HEALTH Study
- Decreased oxytocin plasma levels and oxytocin receptor expression associated with aggressive behavior in aggressive-impulsive disorders
- Association of serum homocysteine, folate, and vitamin B12 and mood following the Swank and Wahls elimination dietary interventions in relapsing-remitting multiple sclerosis: Secondary analysis of the WAVES trial
- Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer's Disease
- Reelin plasma levels identify cognitive decline in Alcohol Use Disorder subjects during early abstinence: the influence of APOE4 expression
- Proinflammatory cytokine levels, cognitive function, and suicidal symptoms of adolescents and young adults with major depressive disorder
- Associations of Sleep Duration and Daytime Sleepiness with Plasma Amyloid Beta and Cognitive Performance in Cognitively Unimpaired, Middle-Aged and Older Adult African Americans
- Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease
- Lipid Peroxidation via Regulating the Metabolism of Docosahexaenoic Acid and Arachidonic Acid in Autistic Behavioral Symptoms
- Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease
- Elevated Plasma Levels of Mature Brain-Derived Neurotrophic Factor in Major Depressive Disorder Patients with Higher Suicidal Ideation
- Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus
- IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis-New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases
- Depressive Symptoms and Plasma Markers of Alzheimer's Disease and Neurodegeneration: A Coordinated Meta-Analysis of 8 Cohort Studies
- Cognitive protection and brain entropy changes from omega-3 polyunsaturated fatty acids supplement in late-life depression: A 52-week randomized controlled trial
- Sex- and age-specific prevalence and risk factors of depressive symptoms in Parkinson's disease
- Pterin metabolism, inflammation and oxidative stress biochemical markers in schizophrenia: Factor analysis and assessment of clinical symptoms associations
- Folic Acid Protects against Ethanol-Induced Hepatic Mitophagy Imbalance by ROS Scavenging and Attenuating the Elevated Hcy Levels
- Association of amyloid-beta with depression or depressive symptoms in older adults without dementia: a systematic review and meta-analysis
- Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects
- Plasma neurofilament light chain is not elevated in people with first-episode psychosis or those at ultra-high risk for psychosis
- A neuronal blood marker is associated with mortality in old age
- Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease
- Association of bone turnover markers and cognitive function in Chinese chronic schizophrenia patients with or without vitamin D insufficiency
- Hydrogen sulfide mitigates memory impairments via the restoration of glutamatergic neurons in a mouse model of hemorrhage shock and resuscitation
- Longitudinal Coupling between Eating Disorder Psychopathology and Depression in Patients with Anorexia Nervosa and Bulimia Nervosa Treated with Enhanced Cognitive Behavior Therapy: A One-Year Follow-Up Study
- Autoantibodies against acetylcholine receptors are increased in archived serum samples from patients with schizophrenia
- Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder
- Factors Associated With Cognitive Improvement After Bariatric Surgery Among Patients With Severe Obesity in the Netherlands
- Activating transcription factor (ATF) 6 upregulates cystathionine β synthetase (CBS) expression and hydrogen sulfide (H2S) synthesis to ameliorate liver metabolic damage
- The Effect of Adjuvant Therapy with Molecular Hydrogen on Endogenous Coenzyme Q10 Levels and Platelet Mitochondrial Bioenergetics in Patients with Non-Alcoholic Fatty Liver Disease
- Cannabis Use and Biomarkers of Inflammation, Immune Activation, and Microbial Translocation in Persons with HIV
- Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP
- Epigenetic modification related to cognitive changes during a cognitive training intervention in depression
- Genetic and inflammatory effects on childhood trauma and cognitive functioning in patients with schizophrenia and healthy participants